Early access to all drugs for rare diseases is pie in sky unless we tax to pay for it
The row over Skyclarys, a new drug for Friedreich’s ataxia patients, was the political story of the week
See all — The Irish Times →Aggregated from the leading newsrooms of the country. Every story links to its original source.







